AlterNet / By Martha Rosenberg
Straight from the author.

In the pharmaceutical industry’s rush to get drugs to market, safety usually comes last. And the public suffers. In the pharmaceutical industry’s rush to get drugs to market, safety usually comes last. Long studies to truly assess a drug’s risks just delay profits after all — and if problems do emerge after medication hits the market, settlements are usually less than profits. Remember, Vioxx still made money.

The following drugs are so plagued with safety problems, it is a wonder they’re on the market at all. It’s a testament to Big Pharma’s greed and our poor regulatory processes that they are.

Click here to read the complete article.

About the Author Michael Lantz (Big Papa)

The Wellness Warrior™; Health & Leadership/Business Coach, Speaker, Blogger, Author, Ironman Triathlete Helping others live with more health and joy, paying for their dreams and make a difference in the world! Learn more: http://HealthIsAHabit.live

Leave a Reply